Results 61 to 70 of about 5,853 (155)

Comparison of Rifampin and Isoniazid for Latent Tuberculosis Infection in Kidney Transplant Candidates: Focus on Tolerability and Treatment Completion

Transplant Infectious Disease, Volume 28, Issue 2, March/April 2026.
This study comparing 4‐month rifampin with 9‐month isoniazid for latent tuberculosis in kidney transplant candidates showed higher treatment completion rates and no transaminase elevations in the rifampin group. However, some patients experienced an increase in blood pressure while taking antihypertensive medications known to interact with rifampin ...
Jacques Simkins, Julia Bini Viotti, Yoichiro Natori, Shweta Anjan, Adela Mattiazzi, Mariella Ortigosa‐Goggins, Giselle Guerra, David Roth, Warren Kupin, Javier A. Pagan, Franco Cabeza, Gaetano Ciancio, Mahmoud Morsi, Michele I. Morris   +13 more
wiley   +1 more source

Mycobacterium avium Infection in a Domestic Shorthair Cat Following Subdermal Hyaluronic Acid Filler Injection

Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Objective To describe the diagnosis and treatment of a Mycobacterium avium (M. avium) infection in a cat following subdermal hyaluronic acid (HA) filler injection. Animal Studied A five‐year‐old spayed female domestic shorthair cat with chronic inferior lateral entropion and chronic feline atopic skin syndrome (FASS).
Alexandra E. Bergen, Callie Miller, J. Seth Eaton, Lara M. Tomich, Jennifer L. Heyward, Taylor A. Opgenorth   +5 more
wiley   +1 more source

Osteomalacia in an HIV-infected man receiving rifabutin, a cytochrome P450 enzyme inducer: a case report

Annals of Clinical Microbiology and Antimicrobials, 2008
Introduction People infected with human immunodeficiency virus are frequently treated with medications that can induce or inhibit cytochrome P450 enzymes.
Horne Anne M, Thomas Mark G, Grey Andrew, Bolland Mark J   +3 more
doaj   +1 more source

A Case Report on Disseminated Mycobacterium avium Complex Infection in an Otherwise Healthy Individual—A Diagnostic Challenge

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Disseminated Mycobacterium avium complex (MAC) infection can mimic tuberculosis (TB) in immunocompetent individuals, leading to diagnostic and therapeutic challenges. Clinicians should consider nontuberculous mycobacteria (NTM) in patients unresponsive to anti‐tubercular therapy (ATT), especially in endemic regions.
Abdulla Bin Hridoy, Shadman Newaz, Moontasir Ahmed, Jannat Ara Tina, Supritom Sarker, Anika Tabassum, Mohammad Zakaria Al‐Aziz, Md. Robed Amin   +7 more
wiley   +1 more source

Activity Profiling of Nitro‐Substituted Di(Hetero)Aryl 1,3,4‐ and 1,2,4‐Oxadiazoles: Antimicrobial, Cholinesterase Inhibition and Antioxidant Potential

Archiv der Pharmazie, Volume 359, Issue 1, January 2026.
Novel nitro‐substituted diaryl 1,3,4‐ and 1,2,4‐oxadiazoles were synthesised via molecular hybridisation of bioactive heterocycles. Selected derivatives exhibited potent antimicrobial activity, including against Mycobacterium tuberculosis and Staphylococcus aureus, and cholinesterase inhibitory activity, with promising selectivity.
Enikő Šikorová, Šárka Štěpánková, Eva Frýbová, Klára Konečná, Jana Korbielová, Markéta Švarcová, Ondřej Janďourek, Václav Pflégr, Szilvia Bősze, Martin Krátký   +9 more
wiley   +1 more source

A Novel PCD Phenotype: Inherent Mucus Hypersecretion by Patient‐Derived Airway Epithelial Cells

Pediatric Pulmonology, Volume 61, Issue 5, May 2026.
Joseph Castlen, Misael Leon, Sarah Wright, Benjamin Gaston, Laura Smith, Michael D. Davis, Allison Norlander, Andrew Tilston‐Lunel   +7 more
wiley   +1 more source

Molecular characterization of rifabutin-resistance in refractory Helicobacter pylori infection in Taiwan

International Journal of Infectious Diseases
Objectives: To explore the molecular characteristics of rpoB, encoding β-subunit of DNA-directed RNA polymerase, and unravel the link to rifabutin-resistance in patients with refractory Helicobacter pylori infection. Methods: From January 2018-March 2021,
Chia-Jung Kuo, Ngoc-Niem Bui, Jun-Nong Ke, Cheng-Yu Lin, Wey-Ran Lin, Ming-Ling Chang, Hui-Yu Wu, Mei-Zi Huang, Cheng-Hsun Chiu, Cheng-Tang Chiu, Chih-Ho Lai   +10 more
doaj   +1 more source

Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains

BMC Gastroenterology, 2020
Background There is no current standard rescue treatment for dual drug-resistant strains of Helicobacter pylori (H. pylori). This aim of this study was to investigate the efficacy of rifabutin-based triple therapy for patients infected with dual drug ...
Chia-Jung Kuo, Cheng-Yu Lin, Puo-Hsien Le, Pi-Yueh Chang, Chih-Ho Lai, Wey-Ran Lin, Ming-Ling Chang, Jun-Te Hsu, Hao-Tsai Cheng, Chi-Nan Tseng, Chun-Jung Lin, Ming-Yao Su, Sen-Yung Hsieh, Cheng-Tang Chiu   +13 more
doaj   +1 more source

Spherical amorphous nanoparticles loading with antituberculosis substance rifabutin

Тонкие химические технологии, 2010
Properties of spherical amorphous nanoparticles loading with antituberculosis substance rifabutin are described. It was shown that rifabutin is loaded completely when content of the substance is 5% from the mass of carrier.
A. P. Kaplun, N. I. Pakhar’kova, L. A. Poruchikova, D. A. Bezrukov, V. I. Popenko, V. I. Shvets   +5 more
doaj  

Mycobacterial infection and the impact of rifabutin treatment in organ transplant recipients: A single-center study

Saudi Journal of Kidney Diseases and Transplantation, 2015
Tuberculosis (TB) is a frequently encountered infection among organ transplant recipients in developing countries, and the incidence of infection after the first year of transplantation is considerably high.
Payam Tabarsi, Maham Farshidpour, Majid Marjani, Parvaneh Baghaei, Amir Yousefzadeh, Katayoon Najafizadeh, Babak Sharifkashani, Pedram Javanmard, Davood Mansouri, Mohammadreza Masjedi, Aliakbar Velayati   +10 more
doaj   +1 more source